hydralazine has been researched along with Lung Diseases, Interstitial in 1 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birnbaum, B | 1 |
| Sidhu, GS | 1 |
| Smith, RL | 1 |
| Pillinger, MH | 1 |
| Tagoe, CE | 1 |
1 other study available for hydralazine and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Fulminating hydralazine-induced lupus pneumonitis.
Topics: Adult; Antihypertensive Agents; Fatal Outcome; Female; Humans; Hydralazine; Lung; Lung Diseases, Int | 2006 |